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Abstract
Fluid accumulation is critical for lung distension and normal development. The multi-subunit c-amino butyric acid type A
receptors (GABAA) mainly act by mediating chloride ion (Cl
2) fluxes. Since fetal lung actively secretes Cl
2-rich fluid, we
investigated the role of GABAA receptors in fetal lung development. The physiological ligand, GABA, and its synthesizing
enzyme, glutamic acid decarboxylase, were predominantly localized to saccular epithelium. To examine the effect of
activating GABAA receptors in fetal lung development in vivo, timed-pregnant rats of day 18 gestation underwent an in
utero surgery for the administration of GABAA receptor modulators into the fetuses. The fetal lungs were isolated on day 21
of gestation and analyzed for changes in fetal lung development. Fetuses injected with GABA had a significantly higher
body weight and lung weight when compared to phosphate-buffered saline (control)-injected fetuses. GABA-injected fetal
lungs had a higher number of saccules than the control. GABA increased the number of alveolar epithelial type II cells as
indicated by surfactant protein C-positive cells. However, GABA decreased the number of a-smooth muscle actin-positive
myofibroblasts, but did not affect the number of Clara cells or alveolar type I cells. GABA-mediated effects were blocked by
the GABAA receptor antagonist, bicuculline. GABA also increased cell proliferation and Cl
2 efflux in fetal distal lung epithelial
cells. In conclusion, our results indicate that GABAA receptors accelerate fetal lung development, likely through an enhanced
cell proliferation and/or fluid secretion.
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Introduction
The fetal lung undergoes distinct stage-specific changes during
gestation. These stages include embryonic, pseudoglandular,
canalicular, saccular, and alveolar stages. The duration and
developmental changes in each of these stages vary depending on
animal species. Particularly interesting are the canalicular and
saccular stages where the lungs are progressively filled with
increasing amounts of fluid [1]. Lung hypoplasia due to
oligohydramnios occurs when fluid secretion is reduced.
The maintenance and secretion of the fluid are required for
normal lung development [2]. Distal lung epithelial cells are the
sources of this fluid. The fluid is rich in Cl
2 and low in bicarbonate
and proteins. The concentrations of Cl
2 and bicarbonate (in mM)
are 157 and 2.8 in lung fluid when compared to 87 and 19 in
plasma.The high concentrationofCl
2 isduetoa highexpression of
Cl
2 channels during early pregnancy which are drastically down-
regulated at birth [3]. Prior to birth the Cl
2 secretion is replaced by
Na
+ reabsorption due to various physiological stimuli including
epinephrine and thyroid hormones [1]. Up-regulation of Na
+
channels including Na
+-K
+ ATPase occurs at birth to promote fluid
reabsorption and facilitate gas exchange [4]. Reduced fluid
reabsorption is one of the causes of infant mortality [5].
Fetal lung epithelial cells maintain a very high level of
intracellular Cl
2 ([Cl
2]i) due to basolaterally located Na
+-K
+-
Cl
2 cotransporter (NKCC), which mediates Cl
2 influx utilizing
the electrochemical gradient created by Na
+-K
+ ATPase.
Interestingly, NKCC-1 gene knockout does not result in
respiratory defects in mice [6]. On the other hand, Cl
2 effluxes
could be mediated by a number of apical channels including cystic
fibrosis transmembrane conductance regulator (CFTR), Ca
2+-
activated Cl
2 channels, outwardly rectifying Cl
2 channels, and
voltage-gated Cl
2 channels (CLC). CFTR gene knockout is not
lethal in mice [7]. Similarly, lung development is normal at birth
in human cases of cystic fibrosis [8]. Knockdown of CLC-2 in fetal
lung explants reduces fetal cyst size and transepithelial voltage [9].
However, CLC-2 knockout mice do not have any respiratory
anomalies at birth [10]. Although it is possible that gene knockout
mice have developed compensatory mechanisms for the loss of
genes to prevent mortality, these results raise the possibility that
other Cl
2 channels may contribute to fetal lung fluid secretion.
c-aminobutyric acid (GABA) receptors are multi-subunit
receptors and can be classified into 3 subtypes (A, B and C) based
on their pharmacological agonists and subunit composition.
GABAA and GABAC are ionotropic whereas GABAB are G-
protein-coupled and metabotropic in nature. GABAC receptors
mainly consist of r1-3 subunits. GABAA receptors are composed
of at least 3 main subunits a, b, c, and accessory subunits such as
d, e, h, p, and r. Physiologically, GABA receptors are activated
upon binding of the ligand, GABA. The synthesis of GABA is
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isoforms, GAD65 and GAD67 depending on their affinity to its
coenzyme, pyridoxal-59-phosphate. In neurons, GAD65 provides
the synaptic GABA whereas GAD67 contributes to the cytoplasmic
GABA pools. The GAD65 knockout mice are susceptible to
seizures; however, the GAD67 knockout mice die immediately
after birth due to respiratory failure [11,12].
Activation of GABAA receptors leads to opening of the channel
and the conductance of Cl
2 ions. GABAA receptors have been
extensively studied in the brain. They are also localized in
peripheral tissues. We have reported the expression profiles of
GABAA receptor subunits in both adult lung tissue and epithelial
cells [13,14,15]. Co-immunoprecipitation and biotinylation ex-
periments have shown that c2, b2, p, a1 and a3 form functional
GABA receptors on the apical membranes of adult lung alveolar
type II cells. These GABA receptors mediate Cl
2 effluxes in type
II cells. Also, they are critical in maintaining alveolar fluid balance
[14]. The genetic deletion of GABAA receptor subunits c2 and b3
leads to early death [16,17]. However, some b3 knockout mice
survive, develop a cleft palate and show behavioral changes.
Genetic deletion of a1, b2, d, and a6 is not lethal in mice
[18,19,20]. Neurophysiological changes have been reported due to
genetic deletion of GABAB receptor subunits [21].
Our laboratory has reported dynamic expression of GABA
receptor subunits during various stages of fetal lung development
[22].Expression ofa2,a5,a6,b1,c3,andr3decreasesfromday18
of gestation to adult. The expression of a3, c1, c2, h,a n dr3i sa
relatively stable with a slight up-regulation at birth. These subunits
may thus have roles in GABA-mediated fetal lung development and
during birth. On the other hand, the expression of a1, b2, and p
subunits increases from day 18 of gestation to the adult stage,
indicatingtheirpotentialrolesinadulttypeIIcells.Interestingly,the
knockdown of p subunit in adult type II cells inhibits Cl
2 fluxes
[14]. The expression of a4, e,a n dr2 subunits is highly variable. In
embryonal stages, GABA mediates Cl
2 effluxes in neuronal and
non-neuronal tissues [23]. Since Cl
2 secretion is crucial for fetal
lung development and there are no studies indicating the role of
GABA receptors in fetal lung development, we investigated their
roles in fetal lung development. We hypothesized that GABA
receptors may promote fetal lung development by mediating Cl
2
efflux. In the long run, modulation of GABA receptors may aid in
treating fetal lung developmental anomalies.
Materials and Methods
Materials
All the chemicals were purchased from Sigma Aldrich (St. Louis,
MO) unless stated. Bicuculline was from MP Biomedicals (Irvine,
CA). Rabbit polyclonal anti-GABA, anti GAD 65/67, and rabbit
monoclonal anti-Ki-67 and mouse monoclonal anti-a-smooth muscle
actin (a-SMA) were from Abcam (Cambridge, MA). Rabbit
polyclonal anti-surfactant protein (SP)-C (sc-13979) was from Santa
Figure 1. Immunolocalization of GAD and GABA in fetal lungs: Immunohistochemistry was performed to study the
immunolocalization of GAD (A) and GABA (B) on fetal lung tissue sections.
doi:10.1371/journal.pone.0014171.g001
Table 1. Effect of GABA on fetal body and lung weights during fetal lung development.
Condition Fetal body weight (% Control) Fetal Lung weight (% Control) LW/BW (% of Control)
PBS 100.0061.28 100.0062.17 100.0061.47
GABA 105.3461.31
* 118.2662.86
* 112.3662.39
*
Bicuculline 97.6661.46 96.6662.49 99.0662.20
GABA+Bicuculline 101.4362.14
# 100.9263.92
# 99.1562.79
#
The fetal body weights (BW) in uninjected animals were 4.3760.10 grams whereas those injected with PBS were 4.5560.11 grams. Fetal lung weights (LW) in the
uninjected and PBS treatment were 131.2367.05 mg and 136.6964.36 mg, respectively. The LW/BW (expressed as a percent) in PBS-injected fetuses was 3.0260.06.
Values represent means6SEM from 11–35 fetuses isolated from 4–13 rats. All the values were expressed as percents of PBS control.
*p,0.05 v.s. PBS;
#p,0.05 v.s. GABA.
doi:10.1371/journal.pone.0014171.t001
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cell secretory protein (CCSP) was from Seven Hills Affinity
Bioreagents (Cincinnati, OH) whereas mouse monoclonal anti-T1a
(mucin-type transmembrane glycoprotein expressed on alveolar type
I cell) was provided by Dr. Mary C. Williams (Boston University).
Avidin-biotic complex (ABC) staining kit for immunohistochemistry
was from Vector Laboratories (Burlinghame, CA). Synthetic
absorbable and nylon sutures were from Ethicon (Somerville, NJ).
Animal breeding
Timed-pregnant Sprague-Dawley rats were bred in house. The
day that a vaginal plug was found was considered as day 0. At this
time, the female rats were housed separately until used for the
experiments. The animals were also monitored for weight gain
regularly. The rats gained 50–80 grams by day 18 of gestation.
The pregnant animals were maintained on a standard breeder
diet. All the animal experiments were approved by the Oklahoma
State University Animal Care and Use Committee (VM-10–26).
In-Utero drug delivery
A surgical procedure for in utero administration into fetuses of
timed-pregnant rats was done as described before [24]. In brief,
pregnant rats (day 18 of gestation) were initially anesthetized with 5%
isoflurane. The anesthesia was then maintained for the entire
procedure with 1.5–2.0% isoflurane. Following induction, the animal
was placed in dorsal recumbency and prepared for an aseptic surgery.
A lower midline incision was made along the linea alba. The skin was
separated from the underlying fascia. The abdominal muscles were
then incised to expose the gravid uterus. The uterine horns were
gently exposed and the fetuses visualized. Sterile normal saline was
used to prevent any drying of the uterus. Fifty microliters of GABAA
receptormodulators(5 mMGABAand2 mMbicuculline)orvehicle
(sterile phosphate-buffered saline, pH 7.4 or PBS) were injected into
the amniotic fluid of each fetus using a 29-guage needle. Since the
administration volume was approximately 10% of the amniotic fluid,
the final concentrations of GABA and bicuculline were 500 mMa n d
200 mM, respectively. These concentrations were similar to our
previous in vivo studies [14]. The number of fetuses in each pregnant
animal varied from 12–14. We injected 3–4 fetuses with each
treatment and we had 3–4 treatment groups in one animal.Following
the delivery of drugs, uterine horns were gently returned to the
abdominal cavity. The abdominal muscle incision was closed by
simple interrupted sutures using a 4/0 synthetic absorbable suture
material.Later,skin incision was closed by horizontalmattresssutures
using 4/0 nylon suture material. The animals were post-operatively
administered buprenorphine (0.05 mg/kg b.wt) for 2 days at every
12 hour interval by intramuscular route. The animals were observed
daily for wound healing and any signs of infection. Eleven pregnant
animals underwent in utero surgery for the delivery of GABAA
receptor modulators. The number of fetuses injected with each
treatment was 19–35.
Fetal body and lung weights
On day 21 of gestation, the pregnant rats were euthanized by
exposing them to 100% CO2 and fetuses were immediately
isolated from the uterus for further studies. The fetuses were
observed for spontaneous movement following their removal from
amniotic sacs. The fetuses were gently cleaned to remove amniotic
fluid and examined for any gross lesions. We did not find gross
lesions. The fetuses were then weighed. We excluded dead fetuses
(8/141). Later, fetal lungs were isolated en bloc and placed on a
blotting paper to remove blood. The left lung from one of the
Figure 2. Effect of GABAA receptor modulators on histology and morphometry of fetal lungs: Rat fetuses were injected with PBS,
GABA (500 mM), bicuculline (200 mM) or GABA plus bicuculline on day 18 of gestation. The fetal lungs were isolated on day 21. The fetal
lung sections were stained with hemotoxylin-eosin (H & E) for studying the histological changes. (A) H & E images (206) of fetal lungs. Scale bar:
40 mm B) The images were enumerated for number of saccules. Shown are the means6SEM per field. A total of 34–49 microscopic fields from 6–8
animals were evaluated. *p,0.05 v.s. PBS; #p,0.05 v.s. GABA.
doi:10.1371/journal.pone.0014171.g002
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dehyde for assessing histological changes.
Lung morphometry
Therat fetallungsectionswerestained withhemotoxylin-eosinfor
monitoring histological changes. Quantification of sacculeswas done
bycounting thenumber ofsacculesper field in6–8 randomlychosen
fields from each section. The total of 6–8 fetuses from different
animals (n=6–8) were evaluated for lung morphometry. Care was
taken not to include large airways and blood vessels in the fields.
Immunohistochemistry
Immunohistochemistry was performed on 4-mm sections. Lungs
from all the treatment groups (in one animal) were mounted in one
block for tissue processing. Immunohistochemistry was done
exactly as previously stated [25]. Briefly, the slides were first
deparaffinized and treated with 3% H2O2 for 20 minutes. The
slides were then subjected for antigen retrieval by boiling in a
20 mM citrate buffer (pH 6.0) for 20 minutes. Later, the tissues
were permeabilized with 0.5% Triton X-100 for 10 minutes and
blocked by 10% fetal bovine serum for 1 hour. The slides were
then incubated with rabbit polyclonal anti-GAD (1:150), rabbit
polyclonal anti-GABA (1:150), rabbit polyclonal anti-SP-C (1:100),
mouse monoclonal anti-a-SMA (1:250), rabbit polyclonal anti-
CCSP (1:250), mouse monoclonal anti-T1a (1:250), and rabbit
monoclonal anti-Ki-67 (1:250) for overnight at 4uC. The slides
were washed in 50 mM PBS for 15 minutes and incubated either
with goat anti-mouse or goat anti-rabbit antibodies (1:250) for
1 hour at room temperature. Immunoreactivity was visualized
using Vectastain Elite ABC kit. In the negative controls, primary
antibodies were omitted. Non-specific rabbit and mouse IgG
served as additional negative controls. The total numbers of SP-C-
positive cells were counted in three randomly chosen fields for
each treatment. Similarly, the numbers of a-SMA-stained small
airways and blood vessels were counted in five randomly chosen
fields. The number of proliferating cells (in the mesenchyme and
epithelium) was quantified by counting Ki-67- positive cells. The
imaging was done under low (406) and high magnification (1006)
using Nikon Upright microscope (E600) equipped with SPOT
Insight 2 scientific digital camera (Diagnostic Instruments, Sterling
Heights, MI).
Cl
2 efflux Assay
Cl
2 efflux studies were done as described before [14]. Fetal
distal lung epithelial cells (day 19) were isolated as described
previously [22]. In brief, the cells were incubated with the Ringer’s
Figure 3. Effect of GABA on SP-C expression during fetal lung development: GABAA receptor modulators, GABA (500 mM),
bicuculline (200 mM) or GABA and bicuculline were injected into rat fetuses via in utero route of administration. Fetal lungs were
isolated on day 21. Immunohistochemistry was done to study the localization of SP-C. (A) Shown are the representative images. Magnified image
(1006) indicate specific staining in the saccular epithelial cells (arrow), but not in vasculature (arrowhead) and airway epithelium (asterisk). No specific
signals were observed in any of the structures when non-specific rabbit IgG were used. Scale bar: 40 mm. (B) Three random fields per animal were
chosen and SP-C-positive cells were counted. Shown are means6SEM of the number of SP-C-positive cells per field. A total of 5 animals were used for
the SP-C staining. *p,0.05 v.s. PBS; #p,0.05 v.s. GABA.
doi:10.1371/journal.pone.0014171.g003
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36Cl at 37uC for 30 minutes. After
centrifugation, the cell pellets were rapidly re-suspended in 1.2 ml
warm Ringer’s solution with 100 mM GABA and/or 100 mM
picrotoxin, and incubated for 10 minutes. An aliquot of the cells
(200 ml) was removed every 2 minutes and quickly centrifuged
through 200 ml of silicone oil. The
36Cl radioactivity in cell pellets
was counted and normalized to milligram protein. The
36Cl efflux
rate coefficient (k; in min) was determined by linear regression
analysis.
Results
Immunolocalization of GAD and GABA in fetal lung
The GABAA receptors are activated by the ligand, GABA. We
first examined fetal lung tissues for the immunolocalization of the
ligand. GABA was localized to a greater extent in the epithelium
but to some extent in the mesenchyme (Fig. 1). Thus, our results
indicate that the physiological ligand for GABAA receptor
activation exists in fetal lungs. We then studied the immunolocal-
ization of the GABA synthesizing enzyme, GAD, in the fetal lungs.
GAD was mostly localized to the saccular epithelium (Fig. 1).
Thus, fetal lung has machinery for GABA synthesis and the
epithelium might act as the physiological source of GABA during
fetal lung development.
Body and lung weights
We delivered GABA in utero on day 18 of gestation and analyzed
fetal lung development on day 21 of gestation. We did not observe
significant mortality following in utero surgery. The fetal mortality
was 5 percent upon administration of various drugs (5/110).
However, bicucuuline when injected alone caused slightly higher
mortality (3/31). It is unlikely that bicuculline was toxic because
the administration of bicuculline along with GABA did not cause
any mortality (0/20). We did not find any significant differences in
fetal body weights following the administration of sterile PBS when
compared to uninjected fetuses (4.3760.10 v.s. 4.5560.11 grams).
Fetal body weights were increased by 5% following injection of
GABA and bicuclline abolished the increase (Table 1).
The administration of PBS did not affect fetal lung weights
when compared to uninjected fetuses (131.2367.05 v.s.
136.6964.36 mg). GABA significantly increased fetal lung weight
(158.7663.76 mg). The administration of bicuculline did not
Figure 4. Effect of GABA on a-SMA in fetal lungs: Rat fetuses were injected with GABA receptor modulators. Immunohistochemistry
was done for studying the localization of a-SMA, a marker of myofibroblasts. (A) Shown are the representative images. Higher magnification images
indicate specific staining of myofibroblasts in airways (arrow) and vasculature (arrowhead), but not in saccular epithelium (asterisk). Negative controls
(non-specific mouse IgG) were devoid of any staining. Scale bar: 40 mm. (B) Five random fields per animal were chosen and quantified for a-SMA
localization. Shown are means6SEM of the number of a-SMA positive cells per field. A total of 5 animals were used for the a-SMA staining. *p,0.05
v.s. PBS; #p,0.05 v.s. GABA.
doi:10.1371/journal.pone.0014171.g004
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weights were significantly reduced following the administration of
GABA along with bicuculline (144.8365.07 mg). Fetal growth was
also assessed by wet lung weight-to-fetal body weight ratio (LW/
BW) expressed as a percent. A statistically significant increase in
LW/BW was observed following administration of GABA
(3.3860.07 v.s. 3.0260.06). The increase was 12 per cent when
compared to PBS-injected fetuses. Bicuculline effectively reduced
GABA-mediated increase in LW/BW (3.0460.09).
Sacccule number
Since the administration of PBS did not affect fetal body and
lung weights significantly, PBS treatment was used as controls for
histological analysis. Histological examination of lung sections
clearly indicated the differences in lung structure following in utero
administration of GABA receptor modulators. GABA reduced
thickness of alveolar septa and increased the number of saccules
(Fig. 2A). The number of saccules increased to 34.7561.37 per
field following GABA treatment when compared to 26.7160.89
per field in PBS-injected fetuses (Fig. 2B). Bicuculline alone did not
affect the saccule number (25.2661.14 per field). However,
bicuculline decreased the GABA-mediated increase in saccule
number (27.2961.33 per field). Thus, our results indicate that
GABA promotes fetal lung maturity.
Alveolar type II Cells
We further examined if GABA also affected lung maturity
through an increased number of alveolar type II cells. We
analyzed the lung sections for the expression of SP-C, a type II cell
marker. SP-C protein was localized in epithelial cells, but not in
mesenchymal cells (Fig. 3A). Higher magnification images did not
reveal staining in airways, blood vessels and mesenchyme. A
negative control in which primary antibodies were omitted did not
show any signals (data not shown). An additional control using
non-specific rabbit IgG also did not have any signals (Fig. 3A).
These results indicate the specificity of the antibody used. The
numbers of positively stained cells were counted to quantify the
changes (Fig. 3B). GABA significantly increased the number of
Figure 5. Effect of GABA on CCSP and T1a during fetal lung development: Rat fetuses were injected with GABA (500 mM),
bicuculline (200 mM), or GABA plus bicuculline on day 18 of gestation. The fetal lung (day 21 of gestation) tissue sections were processed
for studying the localization of CCSP and T1a. (A) The CCSP staining was observed in airways (arrow), but not in saccular epithelium (asterisk) and
vasculature (arrowhead). (B) The T1a staining was seen lining the saccular epithelium, but not in airway (asterisk) and vasculature (arrowhead). Shown
are the representative images. Scale bar: 40 mm.
doi:10.1371/journal.pone.0014171.g005
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78.2764.41 per field). Bicuculline alone did not affect the number
of SP-C-positive cells (80.7364.82 per field); however, it effectively
inhibited GABA-mediated increase in the number of SP-C-
positive cells (75.9366.14 per field). Thus, our results indicate that
GABA promotes fetal lung maturity as reflected by an increased
number of SP-C-positive cells.
Myofibroblasts
Fetal lung undergoes dynamic changes in mesenchyme during
development. We monitored the mesenchymal changes by
studying the expression of a-SMA following administration of
GABAA receptor modulators. a-SMA is expressed by myofibro-
blast cells in the airway and pulmonary vasculature (Fig. 4A). We
did not observe a-SMA expression in saccular epithelium.
Negative controls without primary antibodies (data not shown)
or with non-specific mouse IgG did not show any signals (Fig. 4A).
GABA significantly lowered the number of a-SMA-positive cells in
vasculature and small airways when compared to control
(7.8860.54 v.s. 11.8861.01 per field) (Fig. 4B). Bicuculline alone
did not affect the a-SMA expression (12.0060.68 per field) but
effectively inhibited GABA-mediated decreases in a-SMA expres-
sion (12.8060.86 per field). We did not find significant differences
in a-SMA staining of the large airways.
Clara cells and Type I cells
We examined the fetal lungs for changes in the expression of
CCSP, a clara cell marker localized in upper airways. CCSP
staining was observed in airway epithelium but not in saccular
epithelium, mesenchyme and blood vessels (Fig. 5A). We did not
find significant differences in CCSP staining following GABA
treatment. Similarly, the other treatments also did not affect the
CCSP staining. Alveolar type I cells can be identified with their
marker protein, T1a. Our immunolocalization results indicate that
T1a specifically stained the apical membranes of saccular
epithelium, but not other structures including airways and
vasculature (Fig. 5B). We did not observe any differences in
staining pattern of T1a following various treatments. The staining
pattern did not allow us to quantify the number of T1a-positive
type I cells.
Figure 6. Effect of GABA on cell proliferation during fetal lung development: Pregnant rats at day 18 of gestation underwent in
utero surgery. The rat fetuses were then injected with PBS, GABA (500 mM), bicuculline (200 mM) or GABA plus bicuculline. Rat fetal lungs were
isolated on day 21. Immunohistochemistry was done for the localization of Ki-67, a marker of cell proliferation. (A) Shown are the representative
images. Higher magnification revealed specific staining in saccular epithelium (arrow), mesenchyme (pound), airway (asterisk) and vasculature
(arrowhead). Scale bar: 40 mm. (B) Three random fields were chosen and quantified for Ki-67 expression in epithelial and mesenchymal cells. Shown
are means6SEM (30 microscopic fields) of the number of Ki-67 positive cells per field. A total of 6 animals were used for the Ki-67 staining. *p,0.05
v.s. PBS; #p,0.05 v.s. GABA.
doi:10.1371/journal.pone.0014171.g006
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The growth of fetal lung is through the dynamic balance of cell
proliferation and differentiation. Cell proliferation was analyzed
by enumerating the numbers of Ki-67-positive cells in both the
epithelium and mesenchyme. The Ki-67-positive epithelial cells
increased significantly following GABA treatment (34.2262.25)
when compared to 26.6761.06 in PBS- injected fetuses (Fig. 6).
Bicucculline alone did not affect proliferation (24.5661.90),
however, it effectively inhibited the GABA-mediated increase in
proliferation (22.1761.44). GABA also increased the number of
Ki-67-positive cells (42.8962.97) in mesenchyme when compared
to 33.3961.80 in PBS injected fetuses. The numbers of Ki-67-
positive mesenchymal cells were 37.1762.11 following the
administration of bicuculline alone, and 38.2862.07 when
injected along with GABA. The total number of Ki-67-positive
cells in PBS-injected animals was 56.0662.34 cells. The
administration of GABA increased Ki-67-positive cells to
77.1164.83. Bicuculline did not affect the total number of Ki-
67-positive cells (61.7263.50), however, it significantly decreased
GABA-mediated increases in Ki-67-positive cells (60.4461.95).
Thus, GABA promoted epithelial and mesenchymal cell prolifer-
ation during fetal lung development.
Cl
2 efflux
GABAA receptor exerts its effects by mediating Cl
2 fluxes. Our
previous study indicated that GABAA receptors mediated Cl
2
efflux in adult type II cells (15). However, it is unknown if GABAA
receptors mediate Cl
2 fluxes in fetal lung epithelial cells. We
hence investigated Cl
2 fluxes in freshly isolated day 19 fetal distal
lung epithelial cells following treatment with GABA alone
(100 mM) or along with picrotoxin (100 mM). We observed a net
decrease in [Cl
2]i concentration over a period of time indicating
that fetal distal lung epithelial cells actively secrete Cl
2 into the
buffer (Fig. 7A). Cl
2 efflux (nmol/min/mg protein) in control cells
was 0.062760.008 (Fig. 7B). GABA increased the Cl
2 efflux to
0.10360.013 which was effectively inhibited by picrotoxin
(0.058560.005).
Discussion
Fetal lung actively secretes Cl
2-rich fluid which is critical for
lung development. GABA receptors mediate Cl
2 efflux in
embryonal cells and modulate proliferation and differentiation in
neuronal and non-neuronal tissues. In the current studies, we
found that the GABA synthesizing enzyme, GAD and GABA were
localized predominantly to the epithelia of the fetal lung. The in
utero administration of GABA during fetal stages resulted in higher
fetal body and lung weights. GABA increased the number of SP-
C-positive type II cells, and decreased a-SMA-positive myofibro-
blasts. GABA increased cell proliferation and Cl
2 efflux in fetal
distal lung epithelial cells. These results indicate that GABA
promotes fetal lung development by increasing proliferation and
differentiation of fetal lung epithelial cells.
The physiological concentration of GABA is high in synaptic clefts
(in mM); however, the concentration of GABA in fetal lung fluid is
unknown. Fetal lungs have the necessarymachineryto synthesize and
probably secrete GABA into the lung lumen. The released GABA
might act in an autocrine and a paracrine fashion to activate GABA
receptors in the epithelia and mesenchyme to elicit specific functions.
In utero administration (day 18 of gestation) of fluorescent
microspheres in mice resulted in their accumulation in lungs and
intestines. However, rate of spontaneous abortion was high [26].
We did not observe significant abortion in rats injected with
GABA receptor modulators on day 18 of gestation. Previous
studies successfully injected adenoviral vectors via in utero of
administration in rats; however, mostly on 16 day of gestation
[24]. The time of administration depends on the aim of the
experiment. We have used rats on day 18 of gestation to
investigate the role of GABA receptors in the canalicular and
saccular stages of lung development.
Intrauterine fetal growth can be measured by fetal birth weight,
and fetal organ weights including lungs. A low birth weight is
associated with increased risk for respiratory distress syndrome and
respiratory diseases in adulthood [27,28]. In utero administration of
GABA during fetal stages resulted in a higher body weight, albeit a
small increase (5.9161.22 percent). GABA also promoted fetal
Figure 7. GABAA receptors mediate Cl
2 efflux in fetal distal lung epithelial cells: Freshly isolated fetal distal lung epithelial cells
(day 19) were labeled with
36Cl in Ringer’s solution. The cells were then incubated without (control) with 100 mM GABA and/or 100 mM
picrotoxin (pic), and incubated for 10 min. An aliquot of the cells (200 ml) was removed every 2 min and quickly centrifuged through 200 mlo f
silicone oil. The
36Cl radioactivity in cell pellets was counted and normalized to mg protein. The
36Cl efflux rate is expressed as nM/mg/min. (A) Time
course, (B)
36Cl efflux rate. Shown are means 6SEM. (n=4 independent preparations). *p,0.05 v.s. control; #p,0.05 v.s. GABA.
doi:10.1371/journal.pone.0014171.g007
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percent). A smaller reduction in fetal body weights (6–8%) and a
large reduction in fetal lung weights (25–30%) following
pulmonary hypoplasia were also reported in rats [29]. Growth
response to tracheal occlusion (TO), a method known to accelerate
fetal lung maturity was higher in lungs of rabbits which were more
mature at the time of occlusion [30]. The TO at canalicular stage
increased LW/BW by 35 per cent. However, TO at the
pseudoglandular stage initially increased LW/BW by 15%
followed by a robust increase (50%) in the later stages. We
instilled GABAA receptor modulators in the canalicular stage of
development in rats. It might also be possible that administration
of GABA at other stages might alter the outcomes.
GABA-injected fetal lungs had a 30% higher number of
saccules when compared to the control. The increased number of
saccules indicated that the GABA-treated lungs were more
mature. In rats, saccule numbers decreased in nitrofen-induced
pulmonary hypoplasia [24]. On the other hand, alveolar saccules
increased following tracheal occlusion, a procedure which
promotes fluid accumulation and lung maturation [31]. Thus,
saccule number can be used as a reliable marker of lung maturity.
Increased saccular space with decreased mesenchymal tissue is
another indication of fetal lung maturity. We have not fixed the
fetal lungs by instillation under constant pressure and hence, the
measure of septal thickening might lead to ambiguous conclusions.
However, saccule formation is independent of fixation; hence valid
conclusions can be made based on saccule quantification [31].
The a-SMA protein is expressed in smooth muscle cells in
developing vasculature and airways. a-SMA expression decreased
in adult mature lungs when compared to day 21 of gestation and
early postnatal life [32]. There was a significantly higher number
of a-SMA positive intra-acinar vessels (,30 mm in diameter) in
human cases of pulmonary hypoplasia when compared to normal
lungs [33]. It is concluded that blood vessel muscularization might
be one of etiological factors for vascular changes in fetal lung
hypoplasia. In nitrofen-induced pulmonary hypoplasia, mesen-
chymal tissue was predominant when compared to epithelial cells
[34]. GABA decreased the numbers of a-SMA-positive cells. Thus,
GABA might have promoted fetal lung maturity by a decrease in
number of a-SMA-positive cells.
GABA increased proliferation in Leydig cells [35]. The
increased saccule number may be due an increase in type II cell
number because GABA increased the number of SP-C-positive
cells. Lung expansion promotes growth before and after birth [2].
One of the possible causes of increased lung weights is increased
cell proliferation. The increased expression of nuclear antigen
protein, Ki-67 is an indication of proliferation since it is not
expressed in resting cells. The Ki-67-positive cells were signifi-
cantly increased following GABA treatment, but the increase was
higher in epithelial cells when compared to mesenchymal cells. A
higher GABA-mediated proliferation in epithelia might be due to
the predominance of GABA receptor subunits such as a4, b1, c,
and p in the epithelium. However, some subunits such as a4
subunits are also present in the mesenchyme [22]. GABA
receptors mediate Cl
2 efflux, leading to opening of volgate-gated
calcium channels. The increased intracellular Ca
2+ concentration
may modulate proliferation, migration, and differentiation. The
net effect depends on the cell types [36,37]. TO increased
proliferation activity in the epithelium when compared to control
fetuses [30].
During fetal lung development, the distal lung epithelial cells
continuously secrete Cl
2 ions which in turn drive the movement of
water into the lung lumen. The increased fluid promotes lung
development. GABA increased Cl
2 efflux in adult lung type II
cells [14]. Our current study also showed that in fetal distal lung
epithelial cells GABA increased Cl
2 efflux which was inhibited by
picrotoxin. Our results are in conformity with previous studies
which indicated GABA-mediated Cl
2 efflux in embryonal cells
[23]. Therefore, GABA-mediated increase in epithelial prolifera-
tion and differentiation of type II cells might be due to increased
Cl
2 secretion.
Gene knockout studies indicate that genetic loss of some GABA
subunits results in severe changes in phenotype. Since GABA is an
inhibitory neurotransmitter, the lethality was thought to be due to
neuronal changes [17,20,21,38]. Since GABA increases Cl
2 efflux
in fetal distal epithelial cells and promotes fetal lung maturity,
pulmonary immaturity observed in knockouts might also be one of
the reasons for the lethal phenotype.
Our present study might have significant implication in
pulmonary diseases associated with fetal lung development,
particularly, those due to impaired fluid secretion. Normal fluid
secretion is essential for fetal lung development and maturation.
Decreased fluid secretion in oliogohydramnios and congenital
diaphragmatic hernia (CDH) leads to pulmonary hypoplasia [39].
Delayed epithelial cell differentiation, along with surfactant
protein deficiency, is found in infants with CDH [40]. The
CDH is a development anomaly of newborns (1 in 2500 births).
CDH accounts for 8% of the major congenital defects and causes
significant mortality (50–60%) in United States and developing
world [41]. Significant morbidity is noted in surviving infants. The
CDH is caused by the rupture of the diaphragm. Herniation of
abdominal organs into the thoracic cavity compresses the fetal
lung and inhibits its development. Thus, CDH is characterized by
pulmonary hypoplasia, left ventricular hypolasia, and pulmonary
hypertension [42,43]. Decreased vasculature with increased
musculature predisposes newborns to pulmonary hypertension
[44,45]. Histologically, the CDH lungs have reduced numbers of
airway divisions, alveoli and arterial branches.
TO by fetal surgery ameliorates pulmonary hypoplasia due to
CDH. The TO increases fluid retention in the lung and thus
promotes fetal development in various animal models. However,
TO decreases the number of type II cells. Since alveolar type II
cells secrete lung surfactant, a reduction in type II cell numbers
might reduce lung surfactant in alveolar space and predispose the
infants to neonatal acute respiratory distress syndrome [46,47].
TO procedure in humans did not improve the CDH prognosis
[47]. However, an improved method using fetoscopic tracheal
balloon occlusion method is under active clinical trials. Our results
revealed that GABA increased SP-C-positive type II cells and fetal
lung development, opening avenues for use in treating CDH. Even
though we used an invasive approach for the delivery of GABA to
fetal lungs, it is possible that GABA can be administered
parenterally/orally to elicit similar effects.
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